Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001221508-13-000012
Filing Date
2013-08-13
Accepted
2013-08-13 14:40:56
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 MLPH FORM 10K 06-30-2013 form10k_june302013.htm 10-K 665633
2 MLPH FORM EX 31 06-30-2013 ex311a_june302013.htm EX-31 7826
3 MLPH FORM EX 31 06-30-2013 ex312a_june302013.htm EX-31 7728
4 MLPH FORM EX 32 06-30-2013 ex32a_june302013.htm EX-32 3934
  Complete submission text file 0001221508-13-000012.txt   2896442

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE - 2013-06-30 mlph-20130630.xml EX-101.INS 248429
6 XBRL SCHEMA FILE - 2013-06-30 mlph-20130630.xsd EX-101.SCH 10936
7 XBRL DEFINITION FILE - 2013-06-30 mlph-20130630_def.xml EX-101.DEF 15994
8 XBRL LABEL FILE - 2013-06-30 mlph-20130630_lab.xml EX-101.LAB 94857
9 XBRL PRESENTATION FILE - 2013-06-30 mlph-20130630_pre.xml EX-101.PRE 63717
Mailing Address SUITE 1023 8721 SANTA MONICA BOULEVARD LOS ANGELES CA 900694507
Business Address DRUG DISCOVERY RESEARCH CENTRE 284 OXFORD STREET, LEEDERVILLE 6007 PERTH, WESTERN AUSTRALIA C3 00000 011-61-8-9443-3011
Molecular Pharmacology (USA) Ltd. (Filer) CIK: 0001191357 (see all company filings)

EIN.: 710900799 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-50156 | Film No.: 131032732
SIC: 2834 Pharmaceutical Preparations